Next Generation Cancer Diagnostic Devices Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Next Generation Cancer Diagnostic Devices Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028.

Cancer diagnosis is a type of process that detects numerous biomarkers, proteins, and specific symptoms that detect cancerous tumors in a patient. The process of detecting cancer involves extensive use of certain technologies and devices specifically used for diagnosis. Cancer diagnostic devices are largely divided into genomics, proteomics, metabolomics, epigenetics, device-based, and tumor biomarker tests. According to the National Cancer Institute, approximately 2 million cancer cases were diagnosed in the United States in 2018, of which nearly 609,640 are expected to cause cancer deaths in the United States.

Market Segments

By Type:

• Next Generation Sequencing
• qPCR & Multiplexing
• Lab-on- a- chip (LOAC)
• Protein Microarrays
• DNA Microarrays
• Reverse Transcriptase-PCR (RT-PCR)

By Application:

• Biomarker Development
• CTC Analysis
• Proteomic Analysis
• Epigenetic Analysis
• Genetic Analysis

Key Players

• Roche Holding Ltd.（Switzerland)
• Abbott Laboratories(US)
• Siemens Healthcare(Germany)
• Agilent Technologies Inc(Germany)
• Illumina Inc.(US)
• Becton Dickinson and Co.(US)
• QIAGEN N.V.(Germany)
• Affymetrix Inc.(US)
• Johnson & Johnson(US)
• Thermo Fisher Scientific Inc.(US)
• Roche Holding Ltd.（Switzerland)
• Life Technologies Corp.(US)
• Luminex Corp.(US)
• Cepheid Inc.(US)
• Allegro Diagnostics Corp.(Brazil)

Scope of the Report

The research study analyzes the global Next Generation Cancer Diagnostic Devices industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Next Generation Cancer Diagnostic Devices Market Report

1. What was the Next Generation Cancer Diagnostic Devices Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Next Generation Cancer Diagnostic Devices Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Next Generation Cancer Diagnostic Devices Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.